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ABSTRACT OF THE THESIS 
PREPARATION OF AN IMMUNOSORBENT AND ITS USE IN THE 
SOLID PHASE EXTRACTION OF BENZODIAZEPINES. 
by 
Jorge E. Quintana 
Florida International University, 2012 
Miami, Florida 
Professor Bruce McCord, Major Professor 
The use of capillary electrophoresis (CE) has been restricted to applications having high 
sample concentrations because of its low sensitivity caused by small injection volumes 
and, when ultraviolet (UV) detection is used, the short optical path length. Sensitivity in 
CE can be improved by using more sensitive detection systems, or by preconcentration 
techniques which are based on chromatographic and/or electrophoretic principles. One of 
the promising strategies to improve sensitivity is solid phase extraction (SPE). Solid 
Phase Extraction utilizes high sample volumes and a variety of complex matrixes to 
facilitate trace detection. To increase the specificity of the SPE a selective solid phase 
must be chosen. Immunosorbents, which are a combination of an antibody and a solid 
support, have proven to be an excellent option because of high selectivity of the antibody. 
This thesis is an exploratory study of the application of immunosorbent-SPE combined 
with CE for trace concentration of benzodiazepines. 
This research describes the immobilization and performance evaluation of an 
immunosorbent prepared by immobilizing a benzodiazepine-specific antibody on 
aminopropyl silica. The binding capacity of the immunosorbent, measured as µg of 
v 
benzodiazepine/ gram of immunosorbent, was 39 ± 10. The long term stability of the 
prepared immunosorbent has been improved by capping the remaining aminopropyl 
groups by reaction with acetic anhydride. The capped immunosorbent retained its binding 
capacity after several uses. 
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Chapter I: Introduction 
Because of the poor concentration limits of detection achieved with capillary 
electrophoresis (CE), its use has been restricted to analysis at high levels of 
concentration. To overcome this weakness several strategies have been proposed. One of 
them, solid phase extraction (SPE) is a promising strategy because allows for the use of 
high sample volumes and with complex matrixes. To increase the robustness of SPE, a 
selective solid phase must be chosen. Immunosorbents, which comprise an antibody with 
a solid support, have proven to be an excellent option because of the high selectivity of 
the antibody. In order to develop a successful technique, proper interfacing of the 
immunosorbent and the CE must be performed. My thesis describes an application of 
immunosorbent-CE for trace concentration of benzodiazepines. To do so, an 
immunosorbent was prepared by coupling of amino silica with a benzodiazepine-specific 
antibody and its binding capacity, and its stability were evaluated.  
Background 
Capillary electrophoresis: 
Capillary electrophoresis (CE) is a very popular, widely accepted analytical technique for 
separation. Its success is because of its ability to determine different analytes 
simultaneously with high efficiency, high resolution, low sample consumption, and short 
analysis time. 
Separation by electrophoresis is obtained by differential migration of solutes in an 
electrical field. In CE, electrophoresis is performed in narrow-bore capillaries (25-75 μm 
inner diameter), which are usually filled with buffer. The use of capillaries has numerous 
advantages over other techniques, particularly with respect to detrimental effects of Joule 
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heating. The high electrical resistance of the capillary enables the application of very high 
electrical fields with only minimal heat generation. Moreover, the large surface area-to-
volume ratio of the capillary efficiently dissipates the heat that is generated. The use of 
the high electrical fields results in short analysis times and high efficiency and resolution. 
Peak efficiency, often in excess of 105 theoretical plates, is the result of the plug profile of 
the electroosmotic flow, an electrophoretic phenomenon that generates the bulk flow of 
solution within the capillary. 1 
It is well known that CE usually suffers from poor concentration sensitivity, especially in 
the most widely used ultraviolet (UV) absorbance detection because of the short optical 
path length and the low volume of material analyzed. To improve sensitivity in CE, 
several strategies have been proposed. Most use more sensitive detection systems and/or 
increasing the sample volumes injected into the electrophoresis medium. Although highly 
sensitive methods of detection are available (e.g., laser-induced fluorescence, mass 
spectrometry), they are   also highly selective and expensive, so UV absorbance detection 
is still the most widely used. When CE is used with UV detection, the best way to 
increase the detection signal is to raise the concentration of the analyte, since the molar 
absorptivity and the optical path length are fixed with the capillary diameter.  
There are two different procedures in which the concentration of the analytes in the 
sample can be increased prior to their separation by CE: 2,3 electrophoresis-based 
methods and chromatography-based methods. Electrophoresis methods 4 rely on the 
difference in electrophoretic mobility of the analytes in different zones. Injections can be 
performed using pressure or voltage. Despite their performance and simplicity, 
electrophoretic methods suffer because sample volume is limited by the dimensions of 
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the capillary. Sample volume limitation can be partially overcome through the use of 
voltage based injection, but this approach generally suffers from poor reproducibility, 
discriminates on the basis of ion mobility and is susceptible to small differences in the 
sample matrix. The main drawback when working with injection procedures is the 
analysis of complex matrixes, since numerous substances may be concentrated 
simultaneously with the analytes, causing interferences and loss of efficiency. 
By contrast, chromatographic methods 5 enable higher sample volumes to be injected 
because the analytes are adsorbed onto a stationary phase. Moreover, the sample clean-up 
in chromatographic methods is effective because the sample matrix can be removed from 
the system. Chromatographic-based preconcentration methods 6 include solid-phase 
extraction (SPE) and solid-phase microextraction (SPME) 7, but SPE is the more widely 
used because it can achieve high concentrations of analyte and is more amenable to polar 
analytes. 
The principle of SPE is similar to that of liquid-liquid extraction (LLE) as it also involves 
the partitioning of solutes between two phases. However, instead of two immiscible 
liquid phases, as in LLE, SPE involves partitioning between a liquid (sample matrix) and 
a solid phase (sorbent). Solid Phase Extraction enables the preconcentration and 
purification of analytes from solution by sorption on a solid sorbent. 
An SPE method always consists of three to four successive steps.5 First, the solid sorbent 
is conditioned using an appropriate solvent, enabling the wetting of the packing material 
and the solvation of the functional groups in the stationary phase. In addition, it removes 
possible impurities initially contained in the sorbent or the packaging. The nature of the 
conditioning solvent depends on the nature of the solid sorbent.  The second step is the 
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loading of the sample through the solid sorbent. Depending on the system used, volumes 
can range from 1 ml to 1 liter. The sample flow-rate through the sorbent should be low 
enough to enable efficient retention of the analytes, and high enough to avoid excessive 
analysis times. During this step, the analytes are concentrated on the sorbent. Even 
though matrix components may also be retained by the solid sorbent, some of them pass 
through, thus enabling some purification of the sample.  The third step is the washing of 
the solid sorbent with an appropriate solvent, having low elution strength, to eliminate 
matrix components that have been retained by the solid sorbent, without displacing the 
analytes.  The final step consists in the elution of the analytes of interest by an 
appropriate solvent, without removing retained matrix components. The solvent volume 
should be adjusted so that quantitative recovery of the analytes is achieved with minimal 
dilution. 
Solid Phase Extraction can solve two main problems in CE analysis; it improves 
sensitivity and cleans the sample. Solid Phase Extraction has been combined with CE 
following different approaches;3 the simplest is to perform the  two procedures 
separately, i.e. off-line, which is often time-consuming and requires manual handling. In 
the in-line SPE-CE approach, an SPE cartridge is inserted near the inlet of the separation 
capillary; the SPE column is an integrated part of the CE capillary and there is no need 
for modification of the commercial CE instrument. Lack of selective sorbents is certainly 
the most important weakness of SPE. There is a lot of interest in developing more 
selective extraction procedures which eliminate the co-extraction of matrix interferences. 
Such highly selective extractions have been obtained through the use of molecularly 
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imprinted synthetic polymers (MIP), restricted access materials (RAMs) and immobilized 
receptor or antibodies (Immunosorbents). 
Immunosorbents: 
Immunosorbents use biological molecules, such as antibodies, and are designed using 
molecular recognition. As a consequence of the high affinity and selectivity of the 
antigen-antibody interaction, they permit a high degree of specificity for the analyte. 
Immunosorbents enable the concentration of individual compounds or classes of 
compounds, from liquid matrices in one step and the sample purification of extracts from 
solid matrices. Immunosorbents are obtained by preparing covalently immobilized or 
adsorbed antibodies onto a solid support, which is then packed in a cartridge or a column, 
depending of its use as a chromatographic support or as an extraction media. 
Forces involved in antigen-antibody reactions: 8 
Affinity reactions include a large family of noncovalent binding interactions between 
molecules that depend on structural relations between the two reactants. The forces 
governing these interactions are relatively simple and involve the basic forces employed 
to maintain the conformational structure and integrity of macromolecules. The molecule 
to be isolated binds to the ligand and is held by a series of forces generated by 
interactions between the two molecules. The forces that link antigens and antibodies are 
of four types and their intensity is variable: van der Waals forces are the weakest, of the 
order of 0.5 kcal/mole versus 2 to 5 kcal/mole for electrostatic forces or hydrogen bonds. 
They are, in any case, of lesser strength than that of covalent forces, which reach 50 to 
150 kcal/mole. It is important to note that these forces increase proportionally to the 
distance between antigen an antibody molecules. They are strongest at shorter distances, 
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especially when the two structures are complementary. Increased stability of the antigen-
antibody combination is seen when the contact area widens. The theoretical distance 
between antigen and antibodies sites may also be influenced by the flexibility of the 
antibody molecule, which may allow certain residues to approach closer during contact 
with the antigen. Van der Waals forces are important bonding forces and are generated by 
interactions between the electron clouds of the two molecules. These interactions cause a 
temporary electron disturbance, which causes dipoles to form in both molecules. The two 
dipoles then set up a series of attractive forces between the molecules. As the displaced 
electrons swing back through equilibrium, the dipoles oscillate, which generates an 
attractive force that is inversely proportional to the seventh power of the distance. The 
coulombic forces that arise from the attraction between two oppositely charged ionic 
groups are the second most important force. Such groups could be reactive ionized amino 
(NH3+) groups on one molecule attracting ionized carboxyl (COO-) groups on the other. 
The attractive force created is inversely proportional to the square of the distances 
between the opposite charges. Ion attractive forces are also known as hydrophobic forces 
and again results from the close proximity of one molecule to the other. This coming-
together of the molecules forces water from between them, thus reducing the net charge. 
When two molecules are compatible, they prefer to remain in this low energy state and 
thus in close proximity to each other. The closeness of the two molecules allows the 
fourth bonding force, hydrogen bonding. Hydrogen bonding forms when the weak 
attractive forces formed between hydrophilic groups on the two molecules come into 
contact and interact. 
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Antibodies: 9 
Antibody molecules are glycoproteins composed  of one or more units, each containing 
four polypeptide chains: two identical heavy chains (H) and two identical light chains 
(L).The amino terminal ends of the polypeptide chains show considerable variation in 
amino acid composition and are referred to as the variable (V) region to distinguish them 
from the relatively constant (C) region. Each L chain consists of one variable domain V 
and one constant domain C. The H chains consist of a variable domain, VH, and three 
constant domains CH1, CH2 and CH3. Each heavy chain has about twice the number of 
amino acids (MW ~50,000) as each light chain (MW ~25,000), resulting in a total 
immunoglobulin of approximately 150,000.31 
Heavy and light chains are held together by a combination of noncovalent interactions 
and covalent interchain disulfide bonds, forming bilaterally symmetric structure. The V 
regions of H and L chains comprise the antigen-binding sites of the immunoglobulin (Ig) 
molecules. Each Ig monomer contains two antigen-binding sites and is said to be 
bivalent. The hinge region is the area of the H chains between the first and second C  
region domains and is held together by disulfide bonds.31 
Because compounds of low molecular mass are unable to evoke an immune response, 
before immunization they have to be modified by bonding to a large carrier molecule, 
usually a protein such as bovine serum albumin (BSA). 10 Very often is necessary to 
introduce a functional group into the selected molecule in order to make  this coupling 
possible. The design of the so-called hapten is still an important variable when trying to 
obtain antibodies with the required specificity, especially when antibodies are targeted to 
recognizing a whole class of structurally related compounds.11 The functional group that 
8 
is introduced in the antigen molecule should maintain as much as possible the identity of 
the analyte, but the selection is often determine by trial-and-error assays, once the 
antibodies have been obtained. 
Much effort has been made to develop antibodies that are specific for a compound or a 
class of structurally related compounds. De Blas et al.,12 had reported the preparation and 
evaluation of a monoclonal antibody specific for benzodiazepines. They found that the 
prepared monoclonal antibodies bind with the highest affinities to benzodiazepines that 
have a methyl group in position 1 (see fig 1); benzodiazepines that have an electron-
withdrawing substituent in position 7 such as NO2 or Cl, also bind with the high affinities 
while the addition of a Cl in position 9 or elimination of the carbon ring in position 5 has 
a negative effect on the affinity for the antibodies. In a similar fashion Delaunay-
Bertocini et al. 11,13 and Pichon et al. 14,15 have studied the preparation and cross reactivity 
of monoclonal and polyclonal antibodies in the selective enrichment of some organic 
compounds of high interest in environmental applications. The same conclusions apply. 
Subtle changes in molecular structure can have dramatic effects on affinity. 
 
 
 
 
 
 
 
 
9 
4
3
5
6
7
8
9
3'5'
6'
'
'
2
R7
R3
R3
R2
R4
N
N
R1
O
 
Figure 1 Structure of benzodiazepines 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
Solid Support: 
The solid support selected for the immobilization of the antibodies is a critical parameter 
in the design of the immunosorbent. In addition to basic properties such as chemical and 
biochemical inertness, good mechanical stability and uniformity in particle size, the solid 
support should be easily activated to permit antibody attachment, have appropriate pore 
size to contain the  antibodies, and should be hydrophilic in order to avoid any non-
specific interactions. Traditional supports used in high performance immunoaffinity 
chromatography (HPIAC) and CE; include silica 11,13,14,15 monolithic silica 16, synthetic 
polymers 17 and magnetic beads. 18,19  
One advantage of using silica in HPIAC is the availability of this support in a form that is 
both reproducible and that gives good chromatographic efficiency. 20 Silica particles with 
diameters of 3-5µm are now commonly used in HPIAC separations because the relatively 
small particle diameters result in short diffussional distances for solutes, which helps to 
increase mass transfer and allows for rapid, efficient separations. Although silica particles 
with diameters of 5-10 µm and pore sizes of 40-100 Å are commonly used in methods 
such as reversed chromatography, these pore sizes are not appropriate for many proteins20 
because such pores are comparable in size to the proteins, leading to either the exclusion 
of proteins from these pores or slow mass transfer as a result of restricted diffusion. 
Using larger pore sizes also decreases the surface area onto which the ligand can be 
immobilized. Thus silica supports with intermediate pore sizes in the range of 300-500 Å 
are most commonly used with proteins. 
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Silica Activation: 
The most common method of preparing silica for antibody immobilization is to silanize 
the support before coupling the ligand. There are two types of silanization methods: 
aqueous and non-aqueous.21 Available silanes include epoxysilanes, aminosilanes, 
cyanosilanes, sulfhydrylsilanes, phenyl silanes and glycidoxysilanes, in methoxy, ethoxy, 
and chloro forms. It is well known that the siloxane bond between the silanol residue and 
the silane coupling agent is reversible. Monoethoxy-, monomethoxy-, or 
monochlorosilanes have poor stability on inorganic support materials and are lost rapidly 
over time.21 Trifunctional silanes, on the other hand, produce products that have greater 
stability. These silanes couple not only to the silanol residue on the support material’s 
surface, but they bind to each other forming a polymer across the surface of the carrier. 
The heating step after silanization aids in the polymerization reaction by driving off 
water.  
In many cases, after modification with one of the commercially available silanes, 
chemical modifications are performed to change the functional group for later coupling. 
Ernst-Cabrera22 derivatized silicas of different particle and pore size with three different 
silanes. These groups were further modified to yield primary hydroxyl functions. The 
activation of these primary hydroxyl groups with a variety of reagents was studied for the 
purpose of chemically coupling of proteins. Hage’s group from the University of 
Nebraska has been one of the most prolific groups in the study of activation of silica  as a 
support in High Performance Affinity Chromatography (HPAC). Several studies have 
been done by this group in order to develop a N-hydroxysuccinimide-activated silica23 
and evaluate its performance to separate racemic R/S-warfarin. Sulfhydril-reactive 
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silica24 has been prepared by the same group and evaluated   as a support for the 
immobilization of human serum albumin. The main goal of the study was to compare 
different methods of support activation (Maleimide-, and iodoacetyl- activated silica) and 
evaluate the prepared supports based on their retention and ability to separate chiral 
substances such as D/L-tryptophan, R/S-warfarin and R/S-ibuprofen. Roy25 describes the 
preparation of amino functionalized silica with aminopropyldimethylaminosilane, and its 
use in the immobilization of chymotrypsin using a glutaraldehyde silica which was 
obtained by reacting aminopropyl silica with glutaraldehyde.  
Antibody Immobilization: 
 Antibodies can be immobilized on a solid support in different ways, including physical 
adsorption, affinity adsorption, and covalent binding. Physical adsorption has been 
widely used for the coating of microtiter plates in immunoassay technology. Affinity 
adsorption, using proteins A or G immobilized on a stationary phase, permit good 
orientation of the antibody, but the process suffers from the risk of desorption and steric 
problems because of the size of the immobilized antibody. Covalent binding appears to 
be the best process for immobilization as it provides the most stability bond between the 
solid support and the antibody. When compared to adsorptive immobilization technique, 
covalent bonding reduces the leakage of antibodies from the solid support during wash 
and elution steps. There are some common aspects of immobilization processes that 
strongly influence the antigen-sensing ability of immobilized antibodies. Conformational 
changes or denaturation during or after immobilization reduce immunosorbent 
performance.26 When antibodies are directly attached to a surface, antigen capture is 
often interfered by steric hindrances and the limited mobility of the attached antibodies. 
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In order to reduce this constraint antibodies are immobilized via a long and a flexible 
crosslinker. Additionally, the use of a crosslinker reduces the possibility of denaturation 
caused by the interaction antibody-solid support. Crosslinkers are specialized reagents 
having reactive groups that will form a bond between two different molecules. 
Crosslinkers can be divided into three groups:26 Zero-length cross-linkers which mediate 
the conjugation of two molecules by forming a bond containing no additional atom; 
homobifunctional cross-linkers which are molecules containing the same functional 
group at both ends that eventually tie two molecules by covalently reacting with the same 
common groups. These cross-linkers are designed with almost every length and reactivity 
desired. The third group, the heterobifunctional cross-linkers contain two different 
reactive groups that can couple to two different functional targets. These 
heterobifunctional cross-linkers may be selected on their reactivities as well as on the 
length and type of cross-bridge they posses. 
 Antibodies contain several types of reactive groups that can be used to form covalent 
bonds to solid supports. The most frequently used are the amino groups, followed by the 
sulfhydril, carboxyl, hydroxyl and aromatic groups.26,27,28  Some of the methods more 
commonly used are: 
 Reductive amination or the Schiff base method 10: The procedure generally begins with 
diol-bonded silica or with epoxy-activated silica that is hydrolyzed to form diol groups. 
These diol groups are then oxidized by periodic acid to give aldehyde groups, which can 
react with primary amine groups on a ligand to form a Schiff base, which further can be 
stabilized through the use of sodium borohydride.  
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Glutaraldehyde based methods 25,29: Using this method, silica containing amine groups 
are reacted with a dialdehyde (e.g., glutaraldehyde) to produce aldehyde activated silica. 
The activated silica is then reacted with a ligand that contains primary amines, forming a 
Schiff base that is later reduced. 
Carbonyldiimidazole (CDI) based methods 28: This process often begins with diol-bonded 
silica. These groups are reacted with 1,1’-CDI to give imidazolylcarbamate-activated 
silica, which is later reacted with a primary amine on a ligand to form a stable bond 
between the ligand and the support. 
N-hydrosuccinimide (NHS) method 23: This process begins with hydroxyl or amine 
groups on the support, which can be reacted with reagents like disuccinimidyl glutamate, 
disuccinimidyl subarate or disuccinimidyl carbonate to form the linkage ligand-support. 
Maleimide method 24: This method is used for ligands with Sulfhydril groups. In this 
technique, amine-derivatized silica is reacted with a homobifunctional or 
heterobifunctional crosslinking reagent containing at least one maleimide group. The 
maleimido-activated support can then be reacted with a Sulfhydril-containing ligand for 
its immobilization. 
Hydrazine method 11,13,14,15: The carbohydrate moiety found on the Fc portion of 
antibodies has become a favored site for antibody immobilization. This is performed by 
simply oxidizing the antibody’s carbohydrate vicinal hydroxyl group with sodium 
periodate to form a reactive aldehyde function. The aldehyde is then linked to silica 
containing hydrazine, to form stable covalent hydrazine bonds. 
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Applications of immunosorbents: 
Wieboldt et al. 30, describes the use of a benzodiazepine-specific antibody for screening 
small-molecule libraries by immunoaffinity ultrafiltration. The relation between antibody 
concentration and extraction efficiency was studied, and it was found that larger amounts 
of antibody yield LC/MS chromatograms with improved signal-to-noise ratios. The 
correlation between the amount of antibody and signal level, where the amount of 
antibody is the limiting reagent and there is a constant and excess concentration of 
benzodiazepine, can be explained by the fact that there are more available sites for 
binding, resulting in a greater amount of eluted benzodiazepine. According to the authors, 
the procedure demonstrated that the molecular recognition property of the antibody for 
mixtures of related compounds can be used to develop a better understanding of the role 
molecular structure plays in antibody recognition 
Choi J. et al. 31 developed an immunoassay for the detection of methamphetamine in 
urine by capillary electrophoresis (CE) with laser induced fluorescence (LIF). In this 
work the methamphetamine was labeled with fluorescein isothiocyanate (FITC) to 
compete with free methamphetamine in the sample for the antibody binding. The 
detection limit reported was 19.0 ng/ml. Morphine and related compounds were detected 
in urine using a multi-target antibody prepared by conjugation of morphine to BSA.32 The 
analytes were separated by capillary electrophoresis and monitored at 214nm. Recovery 
and limit of detection were 91-105% and 10-20 ng/ml respectively.  
Flunitrazepam and its metabolites in urine have been analyzed  by Deinl and colleagues.33 
The procedure uses on a column-switching technique which used an immobilized 
antibody in an extraction column following concentration on a column filled with 5 µm 
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particles of  LiChrospher 60 RP-select B precolumn,  and separation on a LiChrospher 60 
RP-select B. The limit of detection reported was 2 ng/ml in urine using UV-VIS detection 
at 254 nm.  
Immunoaffinity solid phase microextration probes have been developed by Lord  et al., 7 
for the analysis of 7-aminoflunitrazepam in urine. The drug was extracted by 
immobilized antibodies and analyzed by LC-MS/MS. The developed method had a limit 
of detection of 0.02 ng/ml, with accuracy ranging from 1% to 27% and precision ranging 
from 2% to 10% between the lower and upper limits of quantitation.  In further research 
by the same group, 34 immunoaffinity solid phase microextraction probes were developed 
with antibodies specific for benzodiazepines. The limits of detection were 0.001-0.015 
ng/ml depending on the antibody, and the dynamic range extended from 0.2-2 ng/ml.  
In the environmental field a lot of research has been done to develop immunosorbents for 
analysis of tryclopyr 55, isopruturon 13, triazines 11, propanil 14, and phenylurea 15, among 
others.    
Overall, sensitivity in CE can be improved by using immunosorbent solid phase 
extraction (IS-SPE).  Coupling of SPE with immunosorbent improves the selectivity of 
the sorbent. These coupled techniques (IS-SPE-CE) provide an excellent application for 
the analysis of trace drugs in complex matrices. 
Because of its abundance in proteins and its reactivity, amino groups are the most 
frequently functional groups used for attachment of antibodies to the solid support. In 
order to improve the antibody orientation it is recommended to use a crosslinker, which 
provides functional groups that can be easily activated, minimize the steric hindrance, 
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improve mobility of the attached antibody, and reduce the possibility of denaturation 
caused by the interaction solid support-antibody. 
The preferred method for preparing immunosorbents is covalent binding of the antibody 
to the solid support due to the stability of the formed bond. 
 The goal of this research is to prepare an immunosorbent by coupling an amino 
functionalized silica support with a benzodiazepine-specific antibody; using SMCC and 
2-iminothiolane as amino-reactive crosslinkers.  
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Chapter II: Immunosorbent Preparation 
Introduction: 
The immobilization of biomolecules to solid materials is a frequently used procedure to 
confer a specific affinity activity to the surface. The goal is to attach the fragile ligand in 
such a way as to leave it structurally intact with its active sites easily accessible for 
specific binding to analytes present in the surrounding fluid phase. The solid support 
selected for covalent immobilization of antibodies is of vital importance when designing 
immunosorbents. Silica, a mechanically stable support which is chemically and 
biologically inert, and easily activated   can be chosen with a specific pore sizes that 
made silica useful in the determination and immobilization of   large molecules. 
Commercial silica with different chemical functionalities is now available, making this 
substrate easily activated with wide variety of cross linkers. A very broad classes of 
chemical groups can thus be accessed using this support.  
Determination of the surface solid-supported functional groups is very important from the 
point of view of characterizing the raw material, selecting the appropriate solid support, 
and in optimizing the coupling conditions of ligands. Amino groups on solid supports can 
be quantified by the use of 2,4,6-trinitrobenzene sulfonic acid (TNBS)36, o-
phthaldialdehyde (OPA) 37, and by the well- known Ellman’s reagent.38,39  
When antibodies are used as immobilized biomolecules, they should be immobilized in 
high concentration on the support, and in the proper orientation to produce the highest 
possible capture of the binding analyte. It is best to use the purest antibody in order to 
obtain an immunosorbent with the highest capacity to bind the target compound. The use 
of unpurified antibodies can result in immunosorbents with low binding capacity due to 
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the fact that impurities will also bind the support, affecting the performance. There are 
different schemes for antibody purification 9 but the most important variable to be taken 
in account when developing a purification strategy is the antibody class (IgG, IgM, IgA, 
IgD, IgE). Oriented immobilization of antibodies is a very important issue in optimizing 
antigen detection on solid surfaces. Properly oriented antibodies, with their antigen 
binding sites well exposed to the solution phase, exhibit higher antigen binding capacities 
when compared to randomly oriented antibodies. Most conjugation procedures involve 
coupling antibodies to solid support via the ε-amino groups of their lysine residues, 
which are the second most abundant functional group present in proteins 40. Although this 
conjugation procedure results in a random attachment with some probability of forming 
improperly oriented antibodies, the use of a cross linker (2-iminothiolane) improves the 
orientation and avoids the steric interference with the solid support.41 The reagent 2-
iminothiolane reacts with amino groups in a ring-opening reaction resulting in a 
permanent modification that contains terminal sulfhydril residues.26,42 
In this section silica and the benzodiazepine-specific antibody will be characterized, in 
order to evaluate their main characteristics from the point of view of immobilization. 
After characterization, the immunosorbent will be prepared by reaction of the amino 
silica and the antibody that have been previously activated with the crosslinkers SMCC 
and 2-Iminothiolane respectively.  
Materials and methods 
Chemicals 
2,4,6- trinitrobenzene sulfonic acid (TNBS), sodium tetraborate, glycine, methanol, 
Sodium Phosphate, dimethyl formamide (DMF), succinimidyl 4-(N-maleidomethyl)-
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cyclohexane -1-carboxilate (SMCC), 4-dimethyl-aminopyridine (DMAP), Lowry test kit, 
sodium bicarbonate, sodium dodecyl sulfate, HCl, Gradiant gels (8-15%), with 
Coomassie brilliant blue, dialysis tubing, DEAE, 2-iminothiolane (2-It), Millipore 
Ultracel YM-10 (NMWL= 30,000) Microcon centrifugal filter device, EDTA, antibody 
specific for flunitrazepam (Biogenesis 4510-0004 Flunitrazepam: antibody, sheep. 
serum),  
Instrumentation 
Analyses of protein as well as determination of amino groups were performed on a UV-
Visible Varian Cary 100 Bio. 
Silica characterization: 
The characterization of the amino silica was done by the 2,4,6- trinitrobenzene sulfonic 
acid (TNBS) method 36 (Fig 2). Briefly 0.2 gram of amino silica was reacted with 1.0 ml 
of 0.01 M TNBS in 9.0 ml of 0.1 M sodium tetraborate. A reference sample composed of 
9.0 ml of 0.1 M sodium tetraborate and 1.0 ml of 0.01 M TNBS was prepared.  After 2 h 
at 37º C the silica was sedimented and 1.0 ml of the supernatant solution was diluted with 
5.0 ml of 0.1 M sodium tetraborate, and 0.5 ml of 0.03 M glycine. A blank sample was 
prepared in the same way but 0.5 ml of water was added instead of glycine. After 25 min 
at 25º C 10 ml of cold methanol was added and the absorbance of the sample was read 
against its own blank at 340 nm. The concentration of the amino groups was determined 
from the difference between the absorbance of reference and sample, using a molar 
absorption coefficient of 12400.36  
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  Silica Activation: 
Amino silica was activated by the procedure described by Mallik, et al. 24 (Fig 3). Briefly, 
17 mg of amino silica was reacted for 21 h at room temperature with 400 µl of dimethyl 
formamide (DMF)  which contains 13µM of succinimidyl 4-(N-maleidomethyl)-
cyclohexane -1-carboxylate (SMCC) and 4µM of 4-dimethyl-aminopyridine (DMAP). 
The resulting maleimide-activated silica was washed several times with DMF. Prior to 
immobilization the activated silica was washed three times with 0.1M phosphate buffer 
pH 7.2  
Antibody Characterization: 
The concentration of the antibody was determined by the Lowry method 43, purity and 
structure was determined by SDS PAGE electrophoresis 44, and total amino groups by the 
method proposed by Hermanson. 26 
The Lowry method was performed using a kit obtained from Thermo Scientific Pierce. 
Briefly the method 43 consists of a ten minutes sample or standard incubation with one ml 
of Modified Lowry Reagent. Exactly at the end of the incubation time, 100 µL of 1X 
Folin-Ciocalteu Reagent was added and incubated for 30 min. At the end of the 
incubation period the sample or standard is read at 750 nm.  A calibration curve was 
constructed using a 1 mg/ml BSA solution (Fig. 4). 
To quantify the amino groups in the antibody 26,  100 µg of antibody  was incubated for 2 
h at 37 C with 0.5 ml of  0.01% (w/v) TNBS  prepared in 0.1 M sodium bicarbonate. 
After incubation, 0.5 ml of 10% sodium dodecyl sulfate and 0.25 ml of 1N HCl were 
added. The absorbance of the solution was measured at 335 nm and the number of amino 
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group present was calculated by comparison to a standard curve prepared (Fig. 5) using 
glycine as a standard.   
Purity and structure were measured by SDS-PAGE performed using Phast system 
(Amersham Pharmacia Biotech) apparatus, following the standard procedure. Gradiant 
gels (8-15%) were used. Gels were stained with Coomassie brilliant blue. After the gel 
was developed (Fig 6) Rf values for the antibody, and the standard were calculated and a 
graph (Fig. 7) was constructed.  
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Figure 2. Reaction of amino groups with trinitro benzenesulfonic acid (TNBS) 
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Antibody Purification: 
The antibody was purified according to the method proposed by Harlow and Lane 9     
Briefly, 10 mg of crude antibody were incubated with 3 mL of 4M ammonium sulfate 
overnight at 4ºC. Then the mixture was centrifuged at 3000 g for 30 min, the supernatant 
was removed and the pellet was resuspended in 1 mL of 5 mM sodium phosphate. The 
resuspended material was dialyzed against three changes of 5 mM sodium phosphate  pH 
6.5. Once dialyzed the solution remaining in the dialysis bag was mixed with 5 mL of 
DEAE resin and incubated for 1 hour at room temperature. Then the DEAE resin was 
removed by passing the slurry through a filter.  
Antibody Activation: 
The antibody was activated according to the procedure developed by  Gupta 45 (Fig. 8). 
Briefly, 0.17 mg of antibody was incubated at room temperature with 0.8 µl of a 2 mg/ml 
solution of 2-iminothiolane (2-It) prepared in sodium phosphate buffer pH 7.2. After 1.5 
h of incubation the solution was transferred into an Millipore Ultracel YM-10 (NMWL= 
30,000) Microcon centrifugal filter device, centrifuged at 1000g for 10 min,   and washed 
three times with  0.1M phosphate buffer pH 7.2 containing 1mM EDTA. 
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Figure 3. Silica activation with SMCC. Amino silica was activated by the procedure 
described by Mallik, et al. 24 Briefly, 17 mg of amino silica was reacted for 21 h at room 
temperature with 400 µl of dimethyl formamide (DMF)  which contains 13µM of 
succinimidyl 4-(N-maleidomethyl)-cyclohexane -1-carboxilate (SMCC) and 4µM of 4-
dimethyl-aminopyridine (DMAP). 
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Figure 4. Linear regression analysis for protein determination in the range from 12 to 200 
µg/ml. Standard samples were prepared from a 1 mg/ml bovine serum albumin. One ml 
of the corresponding standard was mixed with one ml of modified Lowry reagent, 
incubated for 10 min., followed by the addition of 100 µl of Folin-Ciocalteu reagent and 
incubated for 30 min. (All the reagents used are part of a kit from Thermo  Scientific). 
Standards as well as samples were read a 750 nm. The corresponding equation is y = 
0.0017 + 0.0024x with a coefficient of correlation r2 = 0.9999. The error bars represent a 
range of ±1 standard deviation. 
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Figure 5.  Linear regression for analysis of amino groups on proteins in the range from 10 
to 80 mmol of amino groups. Glycine 99% purity was used as a standard. Standard 
samples were prepared in 0.1M sodium bicarbonate, pH 8.5. One ml of the corresponding 
standard was mixed with 0.5 ml of 0.01% (w/v) TNBS (prepared in 0.1M sodium 
bicarbonate, pH 8.5) and incubated for 2 h. at 37ºC. After this period of time standards 
were mixed with 0.5 ml of 10% sodium dodecyl sulfate and 0.25 ml of 1N HCl and read 
at 335 nm. The corresponding equation is y = 0.0016 + 0.0040x with a coefficient of 
correlation r2 = 0.9994. The error bars represent a range of ±1 standard deviation. 
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Figure 6. Determination of purity in crude antibody by SDS-PAGE. A. Unpurified 
antibody. Total protein/lane = 3 µg. From left to right: Lane 1, standard proteins (from 
top to bottom: Myosin (200000 Da), ß-galactosidase (116250 Da), Phosphorilase B 
(97400 Da), Serum Albumin (66200 Da), Ovalbumin (45000 Da). Lane 2, unpurified 
flunitrazepam specific antibody. B. Purified antibody. Total protein/lane =3µg. From left 
to right: Lane 1, standard proteins (same standard as lane 1 in graph A). Lane 2, Purified 
flunitrazepam specific antibody.  
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Figure 7  Calibration curve for log10 of molecular mass against Rf (mobility relative to the 
tracking dye) by SDS-PAGE. The identities of the proteins used, together with their 
molecular masses, are given in graph 7. The corresponding equation is y = 3.557 – 
0.6164x with a coefficient of correlation r2 = 0.9994. The error bars represent a range of 
±1 standard deviation.  
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Figure 8. Antibody activation with 2-iminothiolane. The antibody was activated 
according to the procedure developed by  Gupta 45. Briefly, 0.17 mg of antibody was 
incubated at room temperature with 0.8 µl of a 2mg/ml solution of 2-iminothiolane (2-It) 
prepared in sodium phosphate buffer pH 7.2. 
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Figure 9 Antibody-silica attachment. Attachment of the antibody to the maleimide-
activated silica was done following the procedure developed for Gupta 45 for conjugation 
of antibodies to enzymes. Briefly, 10 mg of the activated maleimide-activated silica was 
incubated at room temperature with the previously activated antibody (170 µg). After 2 h 
the silica-antibody immunosorbent, (IS) was separated decanted by centrifugation. 
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Attachment of the antibody to silica: 
Attachment of the antibody to the maleimide-activated silica followed the procedure 
developed by Gupta 45 for conjugation of antibodies to enzymes (Fig. 9). Briefly, 10 mg 
of the activated maleimide-activated silica was incubated at room temperature with the 
previously activated antibody (170 µg). After 2 h the silica-antibody immunosorbent, (IS) 
was separated decanted by centrifugation. Three additional washes were done using 0.1M 
phosphate buffer. After the third wash the immunosorbent was reconstituted with 100 µl 
of 0.1M phosphate buffer and stored to 2-8 C. 
Results and Discussion: 
The solid support selected for covalent immobilization of antibodies should be 
chemically and biologically inert easily activated and mechanically stable. In my study 
silica modified with aminopropyl groups has been chosen because this support meets 
almost all the requirements for a good support. In particular its pore size of 300 Å is 
optimal for making the  aminosilica accessible to large antibodies molecules or analytes. 
 For a correct use of a support containing amino groups, a quantitative analysis of the 
number of active  amino groups is required. There are several methods reported in the 
literature to do this, Some of them measured the number  of total amino groups, others 
the number of reactive amino groups. From the point of view of silica functionalization 
our interest was to measure the amino groups available for conjugation, that is why 2,4,6-
trinitrobenzenesulfonic acid (TNBS) was chosen as the method to quantify amino groups 
on silica. The value obtained was 42 µmol of available amino group/ gram of silica. In 
the work done by Mallik, et. al. 24 the total amino groups reported for the same amino 
silica was 328 (± 7) µmol of amino groups per gram of silica, and of them only 4.4% 
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could be activated. Based on this value (328± 7 µmol), the amount of amino groups 
determined for the TNBS method was 13% of the total amino groups present in the silica 
sample, a result that is with good agreement with the 4.4% of activation found for Mallik 
and colleagues.24  
The silica activation was carried out using the procedure proposed by Mallik et al. 24 On 
the basis of the amount of reactive amino groups on amino silica the SMCC used was 18 
mol SMCC per mol of amino group. The high ratio was used to guarantee that all the 
amino groups were activated. On the basis of the total amino groups reported by Mallik, 
the ratio was 2.3 mol SMCC/per mol amino group, which was three times the ratio 
assayed by Mallik (0.57-0.67). Therefore a higher ratio was chosen in order to improve 
the silica activation. Mallik reported that the lower ratio (0.57-0.67, on the basis of the 
total amino groups) was one of the reasons they believed had resulted in a low activation 
numbers for the support. 
The concentration of the antibody (Biogenesis 4510-0004 Flunitrazepam: antibody, 
sheep. serum) determined by the Lowry method was 9.4 mg/ml, which represents a too 
high value for a commercial product seemed to indicate that an unpurified antibody had 
been used. The Lowry method was used to quantify the protein content in the antibody as 
received. When a quick protein determination was required the quantification of protein 
was done by converting absorption measurements at 280 nm according to a conversion 
factor of 1.42 absorbance units mg-1 mL-1 in a one-centimeter cuvette 46. 
From the non-reduced SDS PAGE electrophoresis two peaks can be seen (Fig. 6), which 
correspond to 153000 Daltons (D) and 64000 Daltons, showing that the antibody is not 
pure which also explains the high total protein value obtained using the Lowry test. From 
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the molecular weight of the contaminant (Fig 7) it can be postulated that albumin 
(MW=67000) is the contaminant.  
When performing antibody immobilizations one of the main requirements is to have a 
purified antibody, which can eliminate the potential attachment of unreactive species into 
the solid support, decreasing the amount of binding reactive species. The purification of 
antibodies is one of the most critical steps in the whole process of antibody production. 
Its success depends on many factors, the most critical issue that must be taken in account 
is the antibody class (IgG, IgM, IgE, IgA and IgD) 9. Depending of the class, different 
routes could be chosen for purification. The first purification step involved precipitation 
with ammonium sulfate. Precipitation is based on the fact that most globular proteins 
display lower solubility at high salt concentrations, due to the fact that when high 
concentrations of charged ions are added to proteins in solution, these groups compete 
with proteins for binding to water, removing the water molecules from protein decreasing 
their solubility. Because the resulting antibody could be contaminated with other high-
molecular weight proteins as well as proteins that are trapped in the precipitate, an 
additional purification is required. Ion-exchange purification using DEAE was chosen as 
a second purification step. Purification by ion-exchange is based on the fact that 
antibodies have a more basic isoelectric point than the majority of other serum proteins. 
During this purification step, the pH and the salt conditions of the antibody solution were 
adjusted so that the antibody did not bind to the matrix. Prior to the ion-exchange 
separation to remove unwanted low molecular weight solute from the sample, a 
conventional dialysis step was performed.  After purification a PAGE-SDS test was done 
and only one peak could be seen (Fig. 6), which corresponded to 153 KDalton (KD). The 
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fact that only one peak was present demonstrated that the purification process was 
effective for this class of antibody, and that the antibody molecular weigh was 
approximately 153 KDalton. 
 Once a purified antibody was available the main concern was how many groups were 
available for modification. Because the antibody modification will be done through its 
amino groups, a characterization of the amount of “available” lysine (lysine residue in 
which the ε-amino group is free) is of primary importance. To do this a method using 
TNBS 26,47 was chosen because to its specific reaction with primary amino groups 48. 
The number of amino groups on the purified antibody was calculated based on a 
calibration curve performed using glycine as a standard (Fig 5). In order to evaluate the 
method BSA was run as a control. The value obtained from the BSA sample was 66 mol 
of amino groups per mol of BSA. This value was in very good agreement with the value 
reported in reference 49 (59 lysine residues, 30-35 of which are capable of reacting). The 
value obtained for the antibody was 76 mol of amino group per mol of antibody.  
Heterobifunctional crosslinking agents can be used to control the degree of protein 
conjugation, limiting polymerization and controlling the molar ratio of each component 
in the final complex. In this study SMCC and 2-iminothiolane (2-IT) were chosen 
because their reactivity occurs through the amino groups. SMCC is a water-insoluble, 
stable compound which can be reacted under anhydrous conditions to the amino groups 
on the silica matrix decreasing the possibility of silica hydrolysis. In order to improve the 
attachment an alkylating catalyst (DMAP) was chosen. The NHS ester end of the SMCC, 
reacts with the primary amino group on the aminopropyl silica to form stable amide 
bond, and leave at the other end of the molecule a sulfhydryl reactive group (Fig. 3).26 On 
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the other hand, because of its solubility in water and its reactivity through amino groups, 
2-IT is an appropriate reagent for activation of proteins. The reagent 2-IT is used to 
incorporate thiol groups into proteins by reactions of their lysine amino groups. 2-IT is a 
cyclic imidothioester that react with primary amines in a ring opening reaction (Fig. 8) 
that generates a free sulfhydryl. 26 
As mentioned earlier, antibody activation was performed using the ε amino groups of 
lysine groups, following a procedure developed by Gupta. 39 Hermanson, 26 who 
performed the same antibody activation, suggested a molar ratio of 1.6 mol of 2-
iminothiolane per mol of antibody. Considering that the available amino groups are 76 
mol per mol of antibody, a ratio of 48 moles of amino groups per mol of 2-iminothiolane 
was assayed. With this low ratio a low multi-site attachment occurred, which improved 
the IS performance from the point of view of antibody orientation.  
The coupling reaction between the activated amino silica and the activated antibody (Fig. 
9) was carried out at a ratio of 59 mg of activated silica/ mg of antibody. If all the 
available amino groups has been activated, the amount of SMCC groups available for 
binding are 42 µmol SMCC groups/g silica i.e. 0.42 µmol of SMCC groups are available 
to react with 1 nmol on antibody. This ratio was chosen in order to promote the complete 
antibody binding to the silica activated support. The fact that the antibody has a low 
activation ratio (1.6 mol of 2-iminothiolane per mol of antibody) minimizes the potential 
for multi site attachment that could occur with a highly activated support, reacting with a 
highly activated antibody. 
As a result of the above experiments, the amount of amino groups on the silica, and on 
the antibody were measured and the values obtained were 42 µmol NH2/ g silica, and 76 
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mol NH2/ mol of antibody. Based on the amount of amino groups on the antibody, a ratio 
of amino groups to 2-iminothiolane was chosen, which guarantee a low antibody 
activation. This low activation generates an antibody with few sites available to react 
with the solid support reducing the potential for multi-site attachment. Furthermore a 
high ratio of silica/SMCC was chosen in order to produce a highly activated support 
which binds to the greatest possible amount of antibody. 
The purity of the antibody is the main concern when preparing immunosorbents, owing to 
the fact that impurities can be attached to the solid support decreasing the available places 
for antibody binding, and increasing the probability of non-specific binding. From the 
results of the SDS-PAGE test, it can be seen that the purification procedure developed 
has been effective producing an antibody free of contaminants.  
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Chapter III: Performance evaluation 
Introduction: 
The coupling of electrophoretic methods with mass spectrometric detection procedures 
produces a powerful tool for separation and detection of small amounts of unknown 
samples. Electrospray ionization (ESI) is frequently the method of choice for CE/MS 
because of its versatility and sensitivity. However, the use of ESI imposes limitations on 
the composition of the separation buffer that can be used in the CE separations. To reduce 
problems with ion suppression, background cluster ions and contamination of the MS ion 
optics, a volatile buffer is the choice. The performance of the CE separations will 
normally increase with higher ionic strength, while the high ionic strength is a 
disadvantage in ESI-MS; therefore, compatibility of the separation buffer with the 
electrospray process and the resulting mass spectrometric analysis must be considered.   
A relevant point is that the CE column exits at atmospheric pressure which preserves the 
pressure profile within the column and maintains the resolution. 
 When coupling CE/MS and immunoaffinity interactions, it is important to first optimize 
immunoextraction. As in SPE, Delanay-Bertoncini and Hennion 50 divide the 
immunoextraction procedure in five different steps: (1) conditioning; (2) sample 
application; (3) washing, (4) elution of the target analyte; and (5) regeneration. The 
conditioning step removes the immunosorbent storage solution, and should be performed 
with an appropriate buffer solution that creates a favorable environment for specific 
interactions between the target analyte and the immunosorbent. During the second step, 
sample application, it is important to prevent any loss in recovery that can result from an 
overloading of the immunosorbent capacity and/or low affinity of antibodies toward s the 
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compounds of interest. Washing, the third step, removes interferences without eluting the 
analyte. The purpose of the washing step is to minimize the interference of measurement. 
Strong washing solutions can effectively remove interfering components; however, they 
may elute the analytical components.   The fourth step, elution of the target analyte, can 
be done by a number of different approaches: displacer agents, chaotropic reagents, pH 
variations, and water-organic modifier mixtures. Wieboldt et al.,30 describes the use of a 
benzodiazepine-specific antibody for screening small-molecule libraries. In this work, the 
authors use centrifugal ultrafiltration to separate the non-bonded analytes from the Ab-
drug complex. The disruption of the affinity complex collected on the filter and the 
elution of the benzodiazepines was performed through the addition of 30µL of 1% 
trifluoroacetic acid in water to the filter. According to the authors, elution with 1% TFA 
was sufficient to completely desorb the most strongly bound compounds from the 
antibodies. They also noted that elution with a 20% acetic acid solution produced 
identical results.  The fifth step, the regeneration step, is required for immunosorbent 
reusability; this step is not recommended when complex samples are analyzed. The goal 
of this portion of the project was to evaluate the binding capacity of the prepared 
immunosorbent by measuring the amount of benzodiazepine captured by the 
immunosorbent. 
Materials and methods 
Reagents 
Flunitrazepam and diazepam standards were purchased at 1.0 mg/ml in methanol from 
Cerilliant (Round Rock, TX USA) 
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Instrumentation 
A capillary electrophoresis system (Agilent) connected to a time-of-flight (TOF) mass 
spectrometer (Agilent) equipped with an orthogonal electrospray interface, using the 
following operational parameters: Capillary Voltage, 3800 V; Nebulizer pressure, 5 psi; 
Drying gas, 5 L/min; Gas temperature, 300ºC; Fragmentor voltage, 225V; Skimmer 
voltage, 60V; Octapole RF, 300V; Mass Range (m/z), 50-1000; Resolution, 9500±500 
(922.0098); References masses, 121.0509 and 922.0098. The sheath fluid liquid was 
composed of methanol/water (50/50 v/v), containing formic acid (0.1% v/v). The flow 
rate was 0.5 ml/min with a 1/1000 split ratio. 51 Capillaries with a polyimide coating from 
Polymicro Technologies (Phoenix, AZ) had 50 µm ID and were 80 cm long. New 
capillaries were conditioned  at 10 bar with methanol for ten  minutes, water for 0.5 min, 
0.1 N HCL for  ten minutes, water for 2 minutes, 1 N NaOH for ten minutes, water for 10 
minutes, and finally with running buffer (10 mM ammonium acetate) for 10 minutes. At 
the end of these steps the capillary was conditioned and filled with running buffer. 
Capillaries were coupled to the mass spectrometer via a sheath flow ESI interface 
(Agilent). 
Antibody Binding assay: 
In order to check the performance of the antibody a binding assay was performed based 
on the work done by Wieboldt 30. This assay consisted of an incubation of 100 µl of a 
50µg/ml of flunitrazepam (or diazepam) in 10 mM ammonium acetate pH 6.5 or 0.1 M 
phosphate buffer pH 7.2 with different stoichiometric amounts of antibody. After 1 h 
incubation the solution was diafiltered, and washed two times with ammonium acetate 
buffer pH6.5 or 0.1 M phosphate buffer pH 7.2. Then, 30 µl of a 20% acetic acid or 70:30 
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methanol: water solution was added, incubated for 30 minutes and the solution separated 
by ultrafiltration. The recovered liquid was dried at vacuum and reconstituted in 30 µl of 
ammonium acetate pH6.5 buffer. The reconstituted liquid was analyzed by CE-MS using 
10 mM ammonium acetate pH6.5 buffer as the CE buffer. Sample was applied by 
hydrodynamic injection at the capillary inlet at 10.0 mbar for 5 s. Separation was 
performed under a positive voltage of 30.0 kV . The temperature of the capillary cartridge 
was set at 25ºC.  The TOF-MS analysis was performed in positive ion mode. References 
masses (Purine at 121.0509 m/z and HP0921 at 922.0098 m/z, resolution of 9500 ±500) 
were added to the sheath fluid liquid and continuously monitored to maintain the 
instrument’s calibration.51 Data analysis was performed using Applied Biosystems/MDS-
Sciex Analyst QS software (Frankfurt, Germany) 
Immunosorbent binding assay: 
The immunosorbent (10 mg) was combined with 200 µl of 50µg/ml flunitrazepam or 
diazepam prepared in 0.1 M Phosphate pH 7.2, and incubated for one hour at room 
temperature. The solution was transferred to a 2µm filter and centrifuged at 1000g for 
five minutes. The immunosorbent was washed three times with 100 µl of 0.1M phosphate 
buffer pH 7.2, three times with 100 µl of 10 mM ammonium acetate pH6.5 and incubated 
for 30 min with 75  µl of 20% acetic acid or 70:30 methanol: water solution.  One again 
the solution was transferred to a 2µm filter and centrifuged at 1000g for five minutes. 
The immunosorbent was saved for additional testing and the solution was vacuum dried 
and reconstituted with 30 µl of 10 mM ammonium acetate pH 6.5 and analyzed by CE-
MS using 10 mM ammonium acetate pH 6.5 as the CE buffer. 
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Fig 10 Calibration curve for flunitrazepam in the range from 1.25 to 15 µg/ml. Standards 
were prepared in 10 mM ammonium acetate pH 6.5 from 1 mg/ml solution of 
flunitrazepam in methanol. They were analyzed by CE-MS using 10 mM ammonium 
acetate pH6.5 as the CE buffer and applied by hydrodynamic injection at the capillary 
inlet at 10.0 mbar for 5 s. Separation was performed under a positive voltage of 30.0 kV. 
The temperature of the capillary cartridge was set at 25ºC.  The TOF-MS analysis was 
performed in positive ion mode. References masses (Purine at 121.0509 m/z and HP0921 
at 922.0098 m/z, resolution of 9500 ±500) were added to the sheath fluid liquid and 
continuously monitored to maintain the instrument’s calibration.51 Data analysis was 
performed using Applied Biosystems/MDS-Sciex Analyst QS software (Frankfurt, 
Germany). The corresponding equation and coefficient of correlation are: y=2.01E4 + 
2.19E4 x, r2=0.9893. The error bars represents a range of ±1 standard deviation. 
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Elution testing for the immunosorbent: 
In order to improve the extraction (maximize the extracted drug) and to preserve the 
immunosorbent performance, a test was developed to select the best solution for 
extracting the binding drug. The test utilized was the same as the one used in the 
immunosorbent binding assay procedure, but with some modifications: First different 
solutions were used for drug elution; The tested solutions were methanol: water at 
concentrations of 10:90, 30:70, 50:50, and 70:30. Second elutions were assayed 
consecutively: i.e. there was no additional drug-immunosorbent incubation, and third, the 
solution injected into the capillary was the one used for extraction without any vacuum 
concentration.   
Results and discussion: 
The preliminary binding trials were performed on crude antibody using 10 mM 
ammonium acetate buffer as the binding medium and a 100 µl of a 50 µg/ml of 
flunitrazepam solution, unfortunately the binding of drug to the antibody was negligible. 
This solution was chosen because it was the running buffer in the CE separation and so 
fewer washing steps were needed. Better results were obtained using 0.1M phosphate 
buffer pH 7.2 as the binding medium. Subsequent experiments were performed using 100 
µl of 0.1 M phosphate buffer pH 7.2 with some additional washes steps. The purpose of 
the first washing step (0.1 M Phosphate buffer pH 7.2) was to eliminate non-specific 
binding, which could cause false positive results. Prior to elution, a second washing step 
was used involving 100 µl of 10 mM ammonium acetate pH 6.5. The purpose of this step 
was to remove residual phosphate in the sample which might contaminate the ion 
detector in the MS system. 
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The binding assay was performed on the sample as received, with no purification. The 
obtained value was 0.3 mg of flunitrazepam/ gram of antibody.  
Because this result was very low when compared with reports from other authors, the 
possibility of an unpurified antibody was considered, and a scheme for purification was 
developed as was described in the chapter II (Immunosorbent Preparation). Once a pure 
antibody was available the binding test was performed again, but because only a small 
amount of antibody was available, the binding assay was not performed on the antibody 
but on the immunosorbent which was prepared as previously described. The drug bound 
on 11.5 mg of immunosorbent was 0.45 ± 0.12 µg of flunitrazepam. If the amount of 
antibody attached to the activated silica was 17 mg of antibody/g of silica, a binding 
value of 2.3 ± 0.6 mg of flunitrazepam/ g of antibody or 39 ± 10 µg of flunitrazepam/ g 
of immunosorbent was determined. This value is 62 % of the theoretical value (4.17 mg 
of flunitrazepam/ g of antibody) and is very close to that reported by Delaunay-
Bertoncini 13 which was 38 µg of isoproturon/ g of bonded silica. As can be seen from the 
results, a dramatic improvement (0.3 vs. 2.6 mg drug/g antibody) was reached using a 
purified antibody. This can be explained by the fact that more binding sites were now 
available on the support. 
When performing the elution of Flunitrazepam from the prepared immunosorbent using 
20% acetic acid a change in color was observed in the immunosorbent. This may be 
because at lower pHs silica suffers degradation with the result that the antibody can be 
released from the silica substrate. Alternatively the low pH value may produce a 
permanent denaturation of the antibody, causing a dramatic loss in its binding properties. 
In order to minimize denaturation, an elution solution must be selected which does not 
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damage the immunosorbent and at the same time is enough strong to completely disrupt 
the antibody-drug interaction to give high recovery of the drug. Another requirement of 
the elution solution is that it must work when used in small amounts, in order to yield 
narrow peaks for efficient separations.  
In order to look for the best elution solution a test similar to the binding assay was 
performed by washing the immunosorbent with different solutions.  According to 
Delaunay-Bertoncini et al, 52 elution conditions using water-organic modifier mixtures 
are commonly required to elute small molecules but, because these conditions can 
irreversibly denature antibodies, small volumes and short contact times should be used. 
These two conditions are highly favorable for use with  on-line solid phase extraction 
because with small volumes, as mentioned earlier, narrow peaks can be obtained and, 
with short contact time a fast analysis time can be realized.  Experiments were therefore 
performed by examining an elution solution containing a low content of methanol 
(methanol:water 10:90) while monitoring  recovered value of target compound, then the 
concentration of methanol was gradually increased from 30% to 70% determining its 
effect on recovery. This test was performed on the previously characterized 
immunosorbent, by consecutive extractions, and with no preconcentration step i.e. drug 
was extracted with methanol: water and injected directly into the MS instrument. As can 
be seen on table 1, concentrations lower than 70% in methanol were not strong enough to 
elute the total binding drug, which can be eluted using 70% methanol: water . This can be 
confirmed by the fact that an additional extraction with 20% acetic acid did not release 
additional drug. Also, on table 1 it can be seen that at a ratio of 70% methanol: water  a 
new peak at m/e 346 appeared (Fig. 12) in addition to the normal peak at m/e 314 which 
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was the protonated flunitrazepam.  This peak can be assigned as [M + CH3OH2] + an ion  
adduct, with a molecular weight of 346. Unfortunately this adduct did not appear when 
the standards were prepared in methanol: water 70:30, possibly because the adduct 
formation is favored by the silica- drug-methanol interaction. Because this peak could not 
be reproduced its quantitation was not possible  
A second immunosorbent was prepared following the same preparation procedure, but 
elution was performed using 70% methanol: water . This immunosorbent gave a  value of 
34 ± 7 µg of flunitrazepam/ g of immunosorbent (2.1 ±0.4 mg flunitrazepam / g of 
antibody,  50% of the theoretical value).  The similarity between the binding values 
obtained with these two different immunosorbents demonstrates the reproducibility of the 
preparation procedure, and prove that a concentration of 70% methanol: water works 
similarly to as 20% acetic acid. 
In order to determine the quantity of 70% methanol: water necessary to completely elute 
the bound flunitrazepam, a test was performed by doing consecutive extractions with 75 
µL of 70% methanol: water. The extracted drug was 0.14 µg in the first extraction, and 
no drug was detected on the second and third extractions. From this result it can be 
postulated that 75 µL of 70% methanol: water   is enough to disrupt the antibody-drug 
complex. The absorbent’s capacity from this trial was 14 µg flunitrazepam/ g 
immunosorbent. It can be seen that the immunosorbent lost about 59% of its initial 
retention capacity (34 ± 7 µg of flunitrazepam/ g of immunosorbent). 
Overall, the retention capacity for the immunosorbent prepared as previously described 
(chapter two) was 39 ± 10 µg of flunitrazepam/ g immunosorbent. The fact that another 
immunosorbent prepared with the same technique gave a similar retention capacity (34 ± 
47 
7 µg of flunitrazepam/ g of immunosorbent) demonstrates the reproducibility and 
efficacy of the preparation method. 
70% methanol: water was shown to be the best solution to completely elute the bound 
drug from the immunosorbent, and 70 µL of this mixture was sufficient to completely 
elute the drug contained in the  quantity of  immunosorbent tested . 
The observed change in appearance, and the decrease in retention capacity of the 
immunosorbent, indicated the possibility that the immunosorbent suffers some sort of 
degradation during the elution process. Some authors have suggested that silica at pH 
greater than five (especially at neutral pH) can suffer loss of aminopropyl groups as a 
result of the autocatalytic effect of the amino group.56,57   
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Figure 11. Ion electrochromatogram of 5 µg/ml flunitrazepam standard. Analysis was 
performed by using 10 mM ammonium acetate pH6.5 as the CE buffer and applied by 
hydrodynamic injection at the capillary inlet at 10.0 mbar for 5 s. Separation was 
performed under a positive voltage of 30.0 kV. The temperature of the capillary cartridge 
was set at 25ºC.  The TOF-MS analysis was performed in positive ion mode. References 
masses (Purine at 121.0509 m/z and HP0921 at 922.0098 m/z, resolution of 9500 ±500) 
were added to the sheath fluid liquid and continuously monitored to maintain the 
instrument’s calibration.51 
5 µg/ml Flunitrazepam standard in methanol:water 70:30
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Figure 12 Ion electrochromatogram of extracted flunitrazepam. The presence of a new 
peak at m/z=346 can be seen, this peak can be due to the adduct formation of 
[M+CH3OH2]+. See fig 10 and text for conditions. 
 
 
 
 
[M + CH3OH2]+
Extraction 4   MetOH-Water 70:30
50 
Extraction    Elution Solution 
Ratio methanol:water
Recovered Flunitrazepam
               µg 
Peak area at m/z=346
(Counts) 
1 10:90 0.02 - 
2 30:70 0.03 1.1292E4 
3 50:50 0.02 3.3407E4 
4 70:30 0.01 1.0530E5 
5 20% Acetic acid ND - 
 
Table 1. Effect of increasing percentage of methanol on extraction of binding drug. 
Experiments were performed by examining an elution solution containing a low content 
of methanol (methanol:water 10:90) while monitoring  recovered value of target 
compound, then the concentration of methanol was gradually increased from 30% to 70% 
determining its effect on recovery. This test was performed  by consecutive extractions, 
and with no preconcentration step i.e. drug was extracted with  methanol:water and 
injected directly into the MS instrument. 
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Chapter IV: Stability Improvement: 
Introduction: 
There are two cases of ligand leakage in immunosorbents: leakage into simple aqueous 
solution systems during the storage of immunosorbent, and leakage during 
inmunoadsorption treatment, where unknown enzymes and other substances may play a 
role in releasing the ligand.53  Immunosorbent stability depends on the concentration and 
conformation of the bonded antibodies, and the chemical stability of the support. 
Furthermore, deterioration can occur under external pressure, or as a result of swelling 
caused by the different solvents. Dissociation of the antibody-analyte complex is the step 
that can produce the most damage to the immunosorbent. The use of a very low pH for 
desorption improved the elution, but induced a more rapid loss of antibody activity. 
The chemical stability of the support is a critical issue when performing 
immunoextraction. The stability of silica in aqueous medium depends on pH and 
decreases drastically in alkaline medium. When a silica surface is functionalized with 
amino groups it is expected that the basic character of this function may affect the overall 
chemical stability  ( and reactivity) of the resulting functionalized silica.  Etienne and 
Walcarius 54 have studied the chemical reactivity and stability of aminopropyl-
functionalized silica (APS). They studied the influence of pH on the dissolution of APS 
materials in aqueous medium by monitoring the total soluble silicon-containing species 
that have leached in solution as a function of time and found that the initial pH of the 
suspension has a dramatic effect on the quantity of silicon species liberated in solution, 
even during the first few minutes. The extent of solubilization is very low at pH=1, much 
higher at pH=5.7, and maximal when the solution pH is not controlled, enabling the 
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material to express its total basicity.  In a second experiment they compared the behavior 
of silica based materials in the presence and absence of amino groups that were either 
dispersed in solution or immobilized at the silica surface. By comparing these two 
treatments, it appears that APS dissolution in aqueous medium is mainly due to the 
presence of amino groups. By these experiments, and several others realized by the 
authors,  they concluded that amino groups grafted on the surface of silica gel exist under 
two different forms “free” unprotonated amine (≡SiO− C3H6−NH2) and zwitterion-like 
species (≡SiO¯ , +H3NC3H6−Si≡). These latter forms are much more stable in aqueous 
solution (several hours) while the first ones contribute to a fast hydrolysis reaction of 
Si−O−Si bonds, leading to the leaching of aminopropylsilane.  
Smith and Chen 55found that all surfaces prepared from 3-aminopropyl silanes under all 
conditions studied exhibit hydrolysis, suggesting that the γ-aminopropylsiloxane structure 
is inherently more reactive than other aminoalkylsiloxanes due to their ability to form 
stable cyclic intermediates. They suggest that aminosilanes with shorter or longer alkyl 
linkers than propyl may be good candidates for aqueous applications.  
It can be postulated that the immunosorbent instability was the result of two issues. First, 
the antibody suffers denaturation at low pH. This problem can be avoided by the use of 
70% methanol: water as elution solution, and secondly, the remaining amino groups 
(amino groups that do not react with SMCC) caused an autocatalytic reaction which 
breaks the bonding between the silica support and the functionalized amino groups, 
releasing the attached antibody, and as a result a decreasing binding capacity. The next 
step was to improve the immunosorbent stability by capping the remaining amino groups  
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through reaction with acetic anhydride. It was postulated that with the absence of free 
amino groups a more stable immunosorbent might be obtained. 
Materials and Methods: 
Chemicals and instrumentation described in chapter II and III were also used in this 
chapter. Diazepam was purchased from Cerilliant (Round Rock, TX, USA) as a 1 mg/ml 
in methanol. 
Silica Preparation: 
In order to prepare a more stable immunosorbent, a new preparation process was 
examined in order to cap the remaining amino groups on the silica support: 24 The 
preparation process was similar to the one previously developed with one difference: the 
amino groups remaining on the SMCC activated silica were capped using acetic 
anhydride. To prepare the immunosorbent, 17 mg of amino silica was reacted for 21 h at 
room temperature with 400 µl of dimethyl formamide (DMF)  which contained 13µM of 
succinimidyl 4-(N-maleidomethyl)-cyclohexane -1-carboxilate (SMCC) and 4µM of 4-
dimethyl-aminopyridine (DMAP). Then the silica was transferred to a 2 µm filter and 
centrifuged at 1000g until the activated silica appeared dry. Capping was performed by 
taking the activated silica and adding it to 80 µL of a 1:1 mixture of acetic anhydride and 
pyridine containing 2 mg of DMAP. The mixture was stirred in the dark for 24 hours. 
The capped silica was washed three times with acetonitrile, three times with diethyl ether, 
and dried under vacuum. Prior to immobilization the capped silica was washed three 
times with 0.1 M phosphate buffer pH7.2. The antibody immobilization was done as 
previously reported with no modification.  
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Immunosorbent stability:  
The immunosorbent stability was tested by performing a binding assay at a series of time 
intervals on the newly prepared immunosorbent, using diazepam as the binding drug. 
Figure 13 shows the calibration curve for diazepam and   table 2 shows the results 
obtained.  As can be seen the immunosorbent performance reached a peak at time zero 
i.e. just after preparation and, showed a decrease in performance of about 11% when it 
was tested on the same day for a second binding assay. From the graph it can be seen that 
the immunosorbent performance remains almost stable after three weeks of storage and, 
shows a decrease in performance of about 63% after four weeks of preparation. 
Based on these results a new immunosorbent was prepared and its retention capacity was 
tested. One week after preparation was chosen as the time for initiating the stability test 
to determine the number of times the immunosorbent could be used without its 
performance being affected.  
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Figure 13. Calibration curve for diazepam in the range from 1.25 to 10 µg/ml. Standards 
were prepared in 10 mM ammonium acetate pH 6.5 from 1 mg/ml solution of diazepam 
in methanol. They were analyzed by CE-MS using 10 mM ammonium acetate pH6.5 as 
the CE buffer and applied by hydrodynamic injection at the capillary inlet at 10.0 mbar 
for 5 s. Separation was performed under a positive voltage of 30.0 kV. The temperature 
of the capillary cartridge was set at 25ºC.  The TOF-MS analysis was performed in 
positive ion mode. References masses (Purine at 121.0509 m/z and HP0921 at 922.0098 
m/z, resolution of 9500 ±500) were added to the sheath fluid liquid and continuously 
monitored to maintain the instrument’s calibration.51 Data analysis was performed using 
Applied Biosystems/MDS-Sciex Analyst QS software (Frankfurt, Germany). The 
corresponding equation and coefficient of correlation are: y=4.31E3 + 3.85E3 x, 
r2=0.9868. The error bars represents a range of ±1 standard deviation.  
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Week Binding test 1 
µg diazepam/g IS 
Binding test 2 
µg diazepam/g IS 
Binding test 3 
µg diazepam/g IS 
Binding test 4 
µg diazepam/g IS 
0 27 18 - - 
3 16 18 - - 
4 8 10 6 6 
 
Table 2. Stability of the immunosorbent. The values represents the amount of drug 
extracted with a solution methanol:water 70:30 in µg of diazepam/gram of 
immunosorbent. The test was designed to test how the capping step, improved the 
performance of the immunosorbent. To perform this test the immunosorbent (10 mg) was 
combined with 200 µl of 50µg/ml diazepam prepared in 0.1 M Phosphate pH 7.2, and 
incubated for one hour at room temperature. The solute on was transferred to a 2µm filter 
and centrifuged at 1000g for five minutes. The immunosorbent was washed three times 
with 0.1M phosphate buffer pH 7.2, three times with 10 mM ammonium acetate pH6.5 
and incubated for 30 min 70:30 methanol: water solution.  One again the solution was 
transferred to a 2µm filter and centrifuged at 1000g for five minutes. The immunosorbent 
was saved for additional testing and the solution was vacuum dried and reconstituted with 
30 µl of 10 mM ammonium acetate and analyzed by CE-MS using 10 mM ammonium 
acetate pH 6.5 as the CE buffer. 
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Figure 14 Reproducibility testing for the capped diazepam immunosorbent. The values 
represents the amount of drug extracted with a solution methanol:water 70:30 in µg of 
diazepam/gram of immunosorbent. The test was designed based on the results obtained 
from the previous experiment, and one week was chosen to perform the test, four test 
were performed to evaluate the performance of the immunosorbent after consecutive use. 
The binding assay was performed as described previously. 
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Results and discussion: 
After two tests of the immunosorbent its binding capacity was found to decrease to the 
point that it was no longer detected. Some authors have reported that aminosilica can 
suffer auto degradation, due to the high basicity of the amino groups.54, 55 This 
degradation is more prevalent at pH greater than five. It is possible that this degradation 
can be minimized by capping these amino groups; this capping reaction can be performed 
by reacting the free amino groups with acetic anhydride.  
Tests for stability improvement using the new procedure were performed using a 
different antibody than the one used in the preliminary studies. For these studies, a 
diazepam specific antibody was used. This antibody was chosen because it was pre-
purified which saved preparation time.  In order to evaluate the antibody a binding 
capacity test was performed using the procedure mentioned earlier. Because the goal of 
the study was to analyze flunitrazepam, this binding assay was performed using 
flunitrazepam as the analyte. The result obtained for this binding test was 0.4 µg 
flunitrazepam/ mg antibody. Because this level was relatively low, a new test was 
performed, however in this case diazepam was chosen as the binding drug. The binding 
capacity for the new test was 1.7 ± 0.5 µg of diazepam/mg of antibody, four times larger 
than the value obtained using flunitrazepam as the binding drug. This higher value was 
consistent with the fact that the antibody was raised against diazepam, so it is more 
retentive towards diazepam than flunitrazepam. 
Once the antibody was evaluated, a new immunosorbent was prepared but in this case an 
additional step was included. The remaining amino groups that did no react with the 
SMCC were treated with acetic anhydride in the presence of dimethyl amino pyridine as 
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alkylation catalysts. After a twenty four-hour reaction the capped silica was washed 
several times and antibody was binding as previously described. As was mentioned, this 
additional step was performed to eliminate the remaining amino groups which 
presumably are responsible for the silica degradation and low binding capacity obtained 
following use. Note no additional characterization of the immunosorbent was performed 
at this point.  
To evaluate the immunosorbent stability  a series of binding test were scheduled for the 
same day of preparation and several weeks later, following storage of the immunosorbent 
in phosphate buffer pH 7.2 at 4ºC. Two binding tests were performed immediately after 
immunosorbent preparation and subsequently two binding tests at week three and four 
binding test at week four. The results can be seen on table 2. It can be observed that 
around 33% of the immunosorbent performance has been lost when the immunosorbents 
has been tested the same day of preparation, and the immunosorbent retains its binding its 
binding capacity after three weeks of storage (11% loss based on the second binding test). 
A 70% loss of binding capacity can be seen after four weeks of preparations, and this 
value remains almost constant for the remaining trials that were performed the same day. 
The fact that the immunosorbent’s binding capacity was retained after its second use was 
significant, since when the immunosorbent was prepared with no capping of the 
remaining amino groups, its binding capacity was completely lost once it has been used 
for the second time.  
The dramatic lost of performance observed after the first use can be due  to remaining 
uncapped amino groups which cause a fast initial degradation of silica as suggested by 
Etienne and Walcarius 54, and worsened by the use of phosphate buffer which cause a 
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more deleterious effect on silica than organic-based buffers 56,57. Also, it has been 
reported by Mahon 58 that silica dissolution is highly accelerated under biological ionic 
strength as oppose to pure water at room temperature. With these findings in mind it can 
be said that the loss in performance could also be due to the use of phosphate buffer as 
the washing and storage solution. Another cause of immunosorbent lost of performance 
could be the breaking of the bond between the SMCC and the amino group. This kind of 
leaching has been reported by Gomez de la Torre et al 59 in their work where they 
conjugate oligonucleotides to magnetic nanobeads.   
As can be seen on table 2 a very dramatic lost in performance occur at week four, where 
almost a 55% of binding capacity was lost (based on the binding test performed on week 
three). It can be speculated that degradation of silica caused by amino groups could be the 
result of hydrolysis of the acetamido bonds resulting in the presence of  amino groups on 
the support surface, as reported by Björklund and Hearn 60.  
 The fact that the immunosorbent retains its binding capacity after its first use at weeks 
three and four discards the possibility that the lost of performance was due to antibody 
denaturation caused by  70% methanol elution. These results also indicate that phosphate 
buffer at pH 7.2 is an appropriate storage solution. Based on these results a new 
immunosorbent was prepared and its retention capacity was tested. One week after 
preparation was chosen as the time for testing the IS for the number of times the IS could 
be used without its performance being affected. From figure 14 it can be seen that the IS 
can be used for at least four times after one week of preparation, over which time a  
decrease in performance of about 20% occurs. 
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Overall, from the data provided it can be conclude that the immunosorbent stability can 
be improved by the capping of the unreacted amino groups. There are some other 
variables which decrease the binding ability of the immunosorbent like the breaking of 
the bonds between the amino group and the SMCC molecule, the influence of ionic 
strength and the chemical composition of the buffer, which should be considered when 
developing a robust immunosorbent system. Although, the long term immunosorbent 
stability is not the best it can be said that the prepared immunosorbent shows a good 
performance when it is used as close as possible to the time of preparation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
Chapter V: Conclusions and Future Directions 
Conclusions  
A solid phase immunosorbent was prepared from the reaction between amino silica and 
antibodies raised against flunitrazepam. The immunosorbent specific for flunitrazepam 
gave a binding value of 39 ± 10 µg of flunitrazepam/ g of immunosorbent. The 
preparation of the immunosorbent proved to be reproducible and reliable by the fact that 
a second immunosorbent was prepared following the same procedure and its binding 
value was very similar. 
A purification scheme was developed for the purification of IgG antibody, which proved 
to be very efficient by the fact the no contaminants were present after purification. 
The quantification of the amino groups on silica and on the antibody demonstrated very 
good agreement to the values reported for some authors. 
The prepared immunosorbent has been tested as a solid phase extraction media for the 
analysis of flunitrazepam;  its performance has been satisfactory from the point of view 
of retention and functionality. 
The binding capacity was tested for an antibody specific for diazepam. Its value was 1.7 
± 0.5 µg of diazepam/ mg of antibody.  
The capping of the remaining amino groups on the support improved the stability of the 
immunosorbent. The capped immunosorbent retained its activity after several uses, 
whereas the immunosorbent with no capping that lost its activity just after the first use. 
Future Directions: 
The next step in performing analysis of benzodiazepines using antibodies immobilized on 
silica support is to test the immunosorbent using an in-line procedure. To do this the 
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capillary column must be packed with the immunosorbent. The analysis could be done 
using UV-VIS detection which reduces the need for additional washing steps, thereby 
improving the immunosorbent performance and reducing the analysis time.  
Additional drug classes could be analyzed by immobilization of different selective 
antibodies using the same preparation route and/or different supports like the mesoporous 
silica obtained by the sol-gel process. Using this type of process the packing procedure 
could be avoided because the sol-gel reaction can be performed inside the capillary.  
Additionally, by the proper choice of different precursors, a great variety of ligands may 
be utilized, given the opportunity to test different immobilization techniques. 
The use of aptamers has been gained popularity by the fact that they are more resistant to 
harassing conditions like pH, temperature and solvents than antibodies. Aptamers are 
single-stranded DNA or RNA ligands that can be selected for different targets starting 
from a huge library of molecules containing randomly created sequences.  To develop an 
aptamer specific for benzodiazepines, its immobilization and testing in the determination 
of benzodiazepines and their metabolites in different matrices will be a way of continuing 
the study of binding of molecular recognition ligands.  
It may be useful to study the influence of the phosphate buffer as well as the stability of 
the bond between the amino group on the silica and the SMCC molecule on the 
immunosorbent stability in order to develop an immunosorbent that could be used 
multiple times in biological buffers.  
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